ticagrelor
Ligand Summary
a cyclopentyltriazolopyrimidine, inhibitor of platelet activation and aggregation mediated by the P2Y12 ADP-receptor indicated to reduce the rate of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of myocardial infarction
UNII: GLH0314RVC
PubChem: 9871419
Guide to Pharmacology: 1765
ChEMBL: CHEMBL398435
DrugCentral: 4184
LyCHI: 2AXUW7HYJT92
Target Activities
8 Activities
Items per page:
1 – 8 of 8
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
- | ||||||
- | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
IC50 | ||||||
Ki | ||||||
Ki | NEGATIVE ALLOSTERIC MODULATOR | |||||